98 related articles for article (PubMed ID: 17875735)
1. Aberrant Huntingtin interacting protein 1 in lymphoid malignancies.
Bradley SV; Smith MR; Hyun TS; Lucas PC; Li L; Antonuk D; Joshi I; Jin F; Ross TS
Cancer Res; 2007 Sep; 67(18):8923-31. PubMed ID: 17875735
[TBL] [Abstract][Full Text] [Related]
2. Huntingtin interacting protein 1 is a novel brain tumor marker that associates with epidermal growth factor receptor.
Bradley SV; Holland EC; Liu GY; Thomas D; Hyun TS; Ross TS
Cancer Res; 2007 Apr; 67(8):3609-15. PubMed ID: 17440072
[TBL] [Abstract][Full Text] [Related]
3. Serum antibodies to huntingtin interacting protein-1: a new blood test for prostate cancer.
Bradley SV; Oravecz-Wilson KI; Bougeard G; Mizukami I; Li L; Munaco AJ; Sreekumar A; Corradetti MN; Chinnaiyan AM; Sanda MG; Ross TS
Cancer Res; 2005 May; 65(10):4126-33. PubMed ID: 15899803
[TBL] [Abstract][Full Text] [Related]
4. Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival.
Rao DS; Hyun TS; Kumar PD; Mizukami IF; Rubin MA; Lucas PC; Sanda MG; Ross TS
J Clin Invest; 2002 Aug; 110(3):351-60. PubMed ID: 12163454
[TBL] [Abstract][Full Text] [Related]
5. Functional interplay of p53 and Mus81 in DNA damage responses and cancer.
Pamidi A; Cardoso R; Hakem A; Matysiak-Zablocki E; Poonepalli A; Tamblyn L; Perez-Ordonez B; Hande MP; Sanchez O; Hakem R
Cancer Res; 2007 Sep; 67(18):8527-35. PubMed ID: 17875692
[TBL] [Abstract][Full Text] [Related]
6. Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity.
Böll B; Eltaib F; Reiners KS; von Tresckow B; Tawadros S; Simhadri VR; Burrows FJ; Lundgren K; Hansen HP; Engert A; von Strandmann EP
Clin Cancer Res; 2009 Aug; 15(16):5108-16. PubMed ID: 19671844
[TBL] [Abstract][Full Text] [Related]
7. Structural abnormalities in spermatids together with reduced sperm counts and motility underlie the reproductive defect in HIP1-/- mice.
Khatchadourian K; Smith CE; Metzler M; Gregory M; Hayden MR; Cyr DG; Hermo L
Mol Reprod Dev; 2007 Mar; 74(3):341-59. PubMed ID: 16967501
[TBL] [Abstract][Full Text] [Related]
8. The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas.
Marafioti T; Pozzobon M; Hansmann ML; Ventura R; Pileri SA; Roberton H; Gesk S; Gaulard P; Barth TF; Du MQ; Leoncini L; Möller P; Natkunam Y; Siebert R; Mason DY
Br J Haematol; 2005 Feb; 128(3):333-42. PubMed ID: 15667535
[TBL] [Abstract][Full Text] [Related]
9. Protein expression pattern distinguishes different lymphoid neoplasms.
Fujii K; Kondo T; Yokoo H; Yamada T; Matsuno Y; Iwatsuki K; Hirohashi S
Proteomics; 2005 Nov; 5(16):4274-86. PubMed ID: 16206328
[TBL] [Abstract][Full Text] [Related]
10. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.
Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z
Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies.
Nagel D; Vincendeau M; Eitelhuber AC; Krappmann D
Oncogene; 2014 Dec; 33(50):5655-65. PubMed ID: 24469030
[TBL] [Abstract][Full Text] [Related]
12. Block of T cell development in P53-deficient mice accelerates development of lymphomas with characteristic RAG-dependent cytogenetic alterations.
Haines BB; Ryu CJ; Chang S; Protopopov A; Luch A; Kang YH; Draganov DD; Fragoso MF; Paik SG; Hong HJ; DePinho RA; Chen J
Cancer Cell; 2006 Feb; 9(2):109-20. PubMed ID: 16473278
[TBL] [Abstract][Full Text] [Related]
13. Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomas.
Song L; Zlobin A; Ghoshal P; Zhang Q; Houde C; Weijzen S; Jiang Q; Nacheva E; Yagan D; Davis E; Galiegue-Zouitina S; Catovsky D; Grogan T; Fisher RI; Miele L; Coignet LJ
Cancer Res; 2005 Jun; 65(11):4554-61. PubMed ID: 15930272
[TBL] [Abstract][Full Text] [Related]
14. Huntingtin Interacting Protein 1 mutations lead to abnormal hematopoiesis, spinal defects and cataracts.
Oravecz-Wilson KI; Kiel MJ; Li L; Rao DS; Saint-Dic D; Kumar PD; Provot MM; Hankenson KD; Reddy VN; Lieberman AP; Morrison SJ; Ross TS
Hum Mol Genet; 2004 Apr; 13(8):851-67. PubMed ID: 14998932
[TBL] [Abstract][Full Text] [Related]
15. [Classification of malignant lymphomas].
Murohashi I
Rinsho Byori; 2001 Mar; Suppl 115():54-63. PubMed ID: 11391937
[TBL] [Abstract][Full Text] [Related]
16. Dimeric procyanidin B2 inhibits constitutively active NF-kappaB in Hodgkin's lymphoma cells independently of the presence of IkappaB mutations.
Mackenzie GG; Adamo AM; Decker NP; Oteiza PI
Biochem Pharmacol; 2008 Apr; 75(7):1461-71. PubMed ID: 18275936
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma.
Kiessling MK; Klemke CD; Kaminski MM; Galani IE; Krammer PH; Gülow K
Cancer Res; 2009 Mar; 69(6):2365-74. PubMed ID: 19258503
[TBL] [Abstract][Full Text] [Related]
18. Huntingtin interacting protein 1 Is a clathrin coat binding protein required for differentiation of late spermatogenic progenitors.
Rao DS; Chang JC; Kumar PD; Mizukami I; Smithson GM; Bradley SV; Parlow AF; Ross TS
Mol Cell Biol; 2001 Nov; 21(22):7796-806. PubMed ID: 11604514
[TBL] [Abstract][Full Text] [Related]
19. TP53 mutations in circulating free DNA from Egyptian patients with non-Hodgkin's lymphoma.
Hosny G; Farahat N; Hainaut P
Cancer Lett; 2009 Mar; 275(2):234-9. PubMed ID: 19046801
[TBL] [Abstract][Full Text] [Related]
20. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]